Crosspoint Capital Strategies’s Abbott ABT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q1
Sell
-74,737
Closed -$3.37M 133
2015
Q4
$3.37M Buy
+74,737
New +$3.3M 0.88% 21
2015
Q2
Sell
-2,000
Closed -$93K 604
2015
Q1
$93K Sell
2,000
-9,463
-83% -$435K 0.04% 214
2014
Q4
$516K Buy
11,463
+4,606
+67% +$201K 0.18% 120
2014
Q3
$285K Buy
6,857
+87
+1% +$3.68K 0.21% 79
2014
Q2
$291K Sell
6,770
-109
-2% -$4.28K 0.11% 112
2014
Q1
$265K Hold
6,879
0.11% 110
2013
Q4
$276K Buy
+6,879
New +$254K 0.09% 119

Other funds holding ABT

Crosspoint Capital Strategies's ABT Position: Q1 2016 in Review

Crosspoint Capital Strategies sold out of Abbott (ABT) in Q1 2016, closing a stake of 74,737 shares — an estimated $3.37M sold.

Crosspoint Capital Strategies first reported a position in ABT in Q4 2013 and held it in 7 quarters. The position peaked at $3.37M in Q4 2015. 1,470 funds tracked by Wall St. Rank hold ABT as of Q1 2016.

  • Crosspoint Capital Strategies reported no remaining Abbott position as of Q1 2016 after selling out during the quarter.
  • Crosspoint Capital Strategies sold 74,737 Abbott shares in Q1 2016, an estimated $3.37M.
  • Crosspoint Capital Strategies first reported a position in Abbott in Q4 2013 and held it in 7 quarters.
  • Crosspoint Capital Strategies's Abbott position peaked at $3.37M in Q4 2015.
  • 1,470 funds tracked by Wall St. Rank held Abbott as of Q1 2016.

Based on Crosspoint Capital Strategies's 13F filing for Q1 2016, filed 16 May 2016.